Prevalence of skin disorders in patients seeking health care.
Sung, Sarah M, and Alexa B Kimball. 2013. “Prevalence of Skin Disorders in Patients Seeking Health Care.”. Mayo Clinic Proceedings 88 (7): 776.
Search
Search results
2993 results found
Cutaneous effects of BRAF inhibitor therapy: a case series.
Mattei, P L, M B Alora-Palli, S Kraft, D P Lawrence, K T Flaherty, and A B Kimball. 2013. “Cutaneous Effects of BRAF Inhibitor Therapy: A Case Series.”. Annals of Oncology : Official Journal of the European Society for Medical Oncology 24 (2): 530-37.
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin, Stuart R, Madeleine Duvic, Joan Guitart, Amit G Pandya, Bruce E Strober, Elise A Olsen, Christopher M Hull, et al. 2013. “Topical Chemotherapy in Cutaneous T-Cell Lymphoma: Positive Results of a Randomized, Controlled, Multicenter Trial Testing the Efficacy and Safety of a Novel Mechlorethamine, 0.02%, Gel in Mycosis Fungoides.”. JAMA Dermatology 149 (1): 25-32.
A survey assessment of the recognition and treatment of psychocutaneous disorders in the outpatient dermatology setting: how prepared are we?
Gee, Sarah N, Lisa Zakhary, Nancy Keuthen, Daniela Kroshinsky, and Alexa Boer Kimball. 2013. “A Survey Assessment of the Recognition and Treatment of Psychocutaneous Disorders in the Outpatient Dermatology Setting: How Prepared Are We?”. Journal of the American Academy of Dermatology 68 (1): 47-52.
A new era in skin care: the omics revolution.
Kimball, A B. 2012. “A New Era in Skin Care: The Omics Revolution.”. The British Journal of Dermatology 166 Suppl 2: iii-iv.
Beyond the blot: cutting edge tools for genomics, proteomics and metabolomics analyses and previous successes.
Kimball, A B, R A Grant, F Wang, R Osborne, and J P Tiesman. 2012. “Beyond the Blot: Cutting Edge Tools for Genomics, Proteomics and Metabolomics Analyses and Previous Successes.”. The British Journal of Dermatology 166 Suppl 2: 1-8.
A randomized, double-blind, placebo-controlled, pilot study to assess the efficacy and safety of clindamycin 1.2% and tretinoin 0.025% combination gel for the treatment of acne rosacea over 12 weeks.
Chang, Anne Lynn S, Maria Alora-Palli, Xinaida T Lima, Tiffany C Chang, Carol Cheng, Connie M Chung, Omar Amir, and Alexa B Kimball. 2012. “A Randomized, Double-Blind, Placebo-Controlled, Pilot Study to Assess the Efficacy and Safety of Clindamycin 1.2% and Tretinoin 0.025% Combination Gel for the Treatment of Acne Rosacea over 12 Weeks.”. Journal of Drugs in Dermatology : JDD 11 (3): 333-9.
The canary seems fine: the effects of the economy on job-seeking experiences of recent dermatology training program graduates.
Cheng, Carol Erin, and Alexa Boer Kimball. 2010. “The Canary Seems Fine: The Effects of the Economy on Job-Seeking Experiences of Recent Dermatology Training Program Graduates.”. Journal of the American Academy of Dermatology 63 (2): e23-8.
New antifungal therapies for the treatment of onychomycosis.
Kumar, Sandeep, and Alexa B Kimball. 2009. “New Antifungal Therapies for the Treatment of Onychomycosis.”. Expert Opinion on Investigational Drugs 18 (6): 727-34.
Recent changes in the workforce and practice of dermatologic surgery.
Tierney, Emily P, William Hanke, and Alexa Boer Kimball. 2009. “Recent Changes in the Workforce and Practice of Dermatologic Surgery.”. Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.] 35 (3): 413-9.